Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Cell Commun Sign 11:118
Peptide / Compound Information Source: PubChem for research reference only
At 10 years, the survival probability was 96.9% for GLP-1RA use and 76.4% for insulin/metformin use
Our team of professionals is ready to assist you in navigating the plethora of weight loss solutions and choosing the one that best suits your needs and circumstances
SEMAGLUTIDE (GLP-1) Mimics one hormone (GLP-1) to help control hunger Slows how fast your stomach empties so you feel fuller, longer Helps you eat less and lose weight steadily Proven benefits for heart and kidneys TIRZEPATIDE (GIP + GLP-1) Mimics two hormones (GIP + GLP-1) for greater impact Boosts metabolism and helps your body use energy better Often leads to more weight loss than GLP-1 medications Helps improve insulin use and lower blood sugar We offer two entry points Therapy Initiation For those new to Medical Weight Loss Dose slowly increased to minimize side effects Therapy Bridging Transitioning medications Patients with current or previous GLP-1 self-administration Were here to help you feel confident, healthy, and empowered in your weight loss journey
Semaglutide is a GLP-1 (glucagon-like peptide 1) receptor agonist, while tirzepatide is a dual agonist
US$ 25.03
US$ 20.83
US$ 29.94
US$ 27.50
